PILMAN » Cost http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Ticking Some Right Boxes Biosimilar Drugs’ Acceptance Gaining Steam in India http://www.tapanray.in/ticking-some-right-boxes-biosimilar-drugs-acceptance-gaining-steam-in-india/?utm_source=rss&utm_medium=rss&utm_campaign=ticking-some-right-boxes-biosimilar-drugs-acceptance-gaining-steam-in-india http://www.tapanray.in/ticking-some-right-boxes-biosimilar-drugs-acceptance-gaining-steam-in-india/#comments Sun, 24 Sep 2023 06:26:00 +0000 Tapan Ray http://www.tapanray.in/?p=10828 Continue reading →]]> http://www.tapanray.in/ticking-some-right-boxes-biosimilar-drugs-acceptance-gaining-steam-in-india/feed/ 0 Criticality of Bridging the Skill Gap in Today’s Indian Pharma Industry http://www.tapanray.in/criticality-of-bridging-the-skill-gap-in-todays-indian-pharma-industry/?utm_source=rss&utm_medium=rss&utm_campaign=criticality-of-bridging-the-skill-gap-in-todays-indian-pharma-industry http://www.tapanray.in/criticality-of-bridging-the-skill-gap-in-todays-indian-pharma-industry/#comments Sun, 17 Sep 2023 07:14:41 +0000 Tapan Ray http://www.tapanray.in/?p=10820 Continue reading →]]> http://www.tapanray.in/criticality-of-bridging-the-skill-gap-in-todays-indian-pharma-industry/feed/ 0 Drug Prescription In Generic Names Only, No Branded Generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=drug-prescription-in-generic-names-only-no-branded-generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/#comments Sun, 20 Aug 2023 07:24:49 +0000 Tapan Ray http://www.tapanray.in/?p=10812 Continue reading →]]> http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/feed/ 0 Meeting India’s Unmet Biologic Drug Needs Some Global Synergy Evident – But Patients Need More http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/?utm_source=rss&utm_medium=rss&utm_campaign=meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/#comments Mon, 17 Jul 2023 00:00:32 +0000 Tapan Ray http://www.tapanray.in/?p=10799 Continue reading →]]> http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/feed/ 0 Exploiting India’s Weakness For Monopolistic Commercial Gain? http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/?utm_source=rss&utm_medium=rss&utm_campaign=exploiting-indias-weakness-for-monopolistic-commercial-gain http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/#comments Mon, 08 May 2023 00:00:11 +0000 Tapan Ray http://www.tapanray.in/?p=10776 Continue reading →]]> http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/feed/ 0 Impact of The Cost of Pharma Marketing Failure On Patients http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/?utm_source=rss&utm_medium=rss&utm_campaign=impact-of-the-cost-of-pharma-marketing-failure-on-patients http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/#comments Mon, 12 Sep 2022 00:00:09 +0000 Tapan Ray http://www.tapanray.in/?p=10707 Continue reading →]]> http://www.tapanray.in/impact-of-the-cost-of-pharma-marketing-failure-on-patients/feed/ 0 To Reduce Disease Burden India Launches A New Study On Access to Affordable Drugs http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/#comments Mon, 28 Mar 2022 00:00:33 +0000 Tapan Ray http://www.tapanray.in/?p=10678 Continue reading →]]> http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/feed/ 0 India Being World’s Third largest Covid Vaccine Maker: Will All Indians Benefit? http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/?utm_source=rss&utm_medium=rss&utm_campaign=india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/#comments Mon, 02 Nov 2020 00:00:30 +0000 Tapan Ray http://www.tapanray.in/?p=10311 Continue reading →]]> http://www.tapanray.in/india-being-worlds-third-largest-covid-vaccine-maker-will-all-indians-benefit/feed/ 0 Taming Two Critical Covid Uncertainties For Pharma’s Sustainable Growth http://www.tapanray.in/taming-two-critical-covid-uncertainties-for-pharmas-sustainable-growth/?utm_source=rss&utm_medium=rss&utm_campaign=taming-two-critical-covid-uncertainties-for-pharmas-sustainable-growth http://www.tapanray.in/taming-two-critical-covid-uncertainties-for-pharmas-sustainable-growth/#comments Mon, 28 Sep 2020 00:00:56 +0000 Tapan Ray http://www.tapanray.in/?p=10275 Continue reading →]]> http://www.tapanray.in/taming-two-critical-covid-uncertainties-for-pharmas-sustainable-growth/feed/ 0 Pharma’s Dual Challenge – To Save Lives And Livelihood http://www.tapanray.in/pharmas-dual-challenge-to-save-lives-and-livelihood/?utm_source=rss&utm_medium=rss&utm_campaign=pharmas-dual-challenge-to-save-lives-and-livelihood http://www.tapanray.in/pharmas-dual-challenge-to-save-lives-and-livelihood/#comments Mon, 29 Jun 2020 00:00:05 +0000 Tapan Ray http://www.tapanray.in/?p=10146 Continue reading →]]> http://www.tapanray.in/pharmas-dual-challenge-to-save-lives-and-livelihood/feed/ 0